Researchers find new target for asthma, allergy drugs

02/15/2008 | Yahoo!

Symptoms of allergic reactions may be prevented without shutting down the body's immune system by targeting the p110delta protein, which has been associated with various diseases, including cancer, a study revealed. A drug targeting the protein could be produced as a capsule for patients with asthma or as a topical medicine for eczema, and drugmakers including Genentech and Pfizer have already expressed interest in developing such a treatment, researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX